Helena Lucente

Business Development | New Product Planning Manager | Search and Evaluation | External Innovation | Alliance Manager

Boston, MA

Message

Connect

Profile:

Evaluation of scientific and commercial potential including market and competitive intelligence of drug candidates and business development opportunities relevant to the PureTech Health Innovations immune/gut/oncology pipeline
Evaluating commercial opportunities of research reagents through analysis of technology application areas, market size, competitive offerings and market need
Business development manager leading in-licensing and out-licensing efforts of research use only and in vitro diagnostic technologies
Alliance manager liaising with companies, inventing scientists, technology transfer offices (TTOs) and interns to identify, perform due-diligence and commercialize life science reagents
Oncological Sciences PhD and Clinical Investigation MS (expertise in oncology, cancer immunology & hematology, molecular biology, epidemiology research)

2018 Nov - Present

Out-Licensing Responsibilities

Managing key commercial accounts, developing new business leads and negotiation, execution and management of new deals with life science reagent companies, pharma and biotech to meet revenue growth targets.
Evaluating commercial opportunities through analysis of technology application areas, market size, competitive offerings and market need.

In-Licensing Responsibilities

Alliance manager between Ximbio and university/research institute TTOs to promote, manage, and commercialize life science reagents.
Managing the portfolios of 20+ university/research institute TTOs.
Recruited, negotiated and closed 13 in-licensing and revenue sharing agreements with university/research institutes. Increasing partnerships in North America by 44% and Total partnerships by 16%.
Established 10 internship programs on university campuses increasing total internship programs in North America by 167% and total programs by 71%. Managed 7 on-campus interns.
Added 365+ tools to Ximbio’s portfolio increasing the tool portfolio size by 19% and managed product logistics and repositories.

2018 Nov - 2019 Jan

Scientific evaluation of drug candidates, market analysis and competitive landscape of autoimmune disorders of interest to PureTech Health.
Evaluated the commercial and repurposing potential of discontinued drug candidates as novel therapeutics for immune/gut/oncology disorders.
Identified, assessed and presented 4 drug candidates to be repurposed as novel therapeutic approaches to the innovation team to guide the company’s commercial development strategy.
Investigated emerging business development opportunities and compiled a database of potential partners in the biotech space with assets of interest to PureTech Health.

2011 - 2018

Huntsman Cancer Institute, University of Utah

Doctor of Philosophy, Oncological Sciences

Master of Science, Clinical Investigation

Designed, implemented, and communicated cancer immunology & hematology/molecular biology research of a high-risk mixed-phenotype acute leukemia mouse model to understand the underlying mechanisms of disease.
Analyzed, interpreted, and communicated cancer immunology & hematology/molecular biology/ epidemiology research identifying familial associations in Langerhans Cell Histocytosis using the Utah Population Database.
Wrote, reviewed, edited and submitted original grant and journal articles (3 hematology articles published, 2 cancer immunology & hematology articles in preparation).